Skip to main content
×
Home
    • Aa
    • Aa

Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods

  • M. E. B. Ramsay (a1), C. P. Farrington (a1) and E. Miller (a1)
Summary
Summary

A national survey was conducted of 3150 notified cases of whooping cough in order to determine age-specific pertussis vaccine efficacy by the ‘screening’ method. The cases were collected over two periods, one just prior to the start and one at the first peak of the whooping cough epidemic of 1989–90. Vaccination status was determined by a postal questionnaire to the reporting doctor and clinical data were also collected to provide efficacy estimates according to standardized case definitions. Overall, observed vaccine efficacy was high but differed between epidemic (87%) and non-epidemic (93%) periods (P = 0·03). Efficacy estimates were generally higher for typical or severe cases than for children with an atypical illness. Vaccine efficacy declined with age (P < 0·01) but estimates remained high up to the age of 8 years. This study will provide baseline data for comparison with efficacy observed from similar studies of children immunized at an accelerated schedule and from phase III studies of acellular pertussis vaccines performed elsewhere.

Copyright
Corresponding author
* Author for correspondence: Dr M. Ramsay, Department of Public Health Medicine, St Mary's Hospital Medical School, Imperial College, Norfolk Place, London W2 1PG.
References
Hide All
1. Department of Health. Immunisation against infectious disease 1990. London: HMSO, 1990.
2.Ramsay MEB, Corbel MJ, Redhead K, Ashworth LAE, Begg NT. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine. BMJ 1991; 302: 1489–91.
3.Booy R, Aitken SJM, Taylor S, et al. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3 and 4 months of age versus 3, 5 and 9 months of age. Lancet 1992; 339: 507–10.
4. Ad-hoc group for the study of pertussis vaccines. Placebo controlled trial of two acellular pertussis vaccines in Sweden - protective efficacy and adverse events. Lancet 1988; i: 955–60.
5.Blackwelder WC, Storsaeter J, Olin P, Hallander H. Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions. Amer J Dis Child 1991; 145: 16.
6. PHLS Epidemiological Research Laboratory and 21 Area Health Authorities. Efficacy of pertussis vaccination in England. BMJ 1982; 285: 357–9.
7.Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10-year community study. BMJ 1988; 296: 612–14.
8.Pollock TM, Miller E, Lobb J. Severity of whooping cough in England before and after the decline in pertussis immunisation. Arch Dis Child 1984; 59: 162–5.
9.Miller E, Jacombs B, Pollock TM. Whooping cough notifications. Lancet 1980; i: 718.
10.Orenstein WA, Bernier RH, Donder TJ, et al. Field evaluation of vaccine efficacy. Bull WHO 1985; 63: 1055–68.
11.Begg NT, Gill ON, White JM. COVER (Cover of Vaccination Evaluated Rapidly): description of the England and Wales scheme. Public Health 1989; 103: 81–9.
12. World Health Organisation. Report of a meeting on the case definition of pertussis. MIM/EPI/PERT/91.1 Geneva: WHO, 1991.
13.Onorato IM, Wassilak SGF. Laboratory diagnosis of pertussis: the state of the art. Paediatr Infect Dis J 1987; 6: 145–51.
14.Jenkinson D, Pepper JD. A search for subclinical infection during a small outbreak of whooping cough: implications for clinical diagnosis. J R Coll Gen Pract 1986; 36: 547–8.
15.Grob PR, Crowder MJ, Robbins JF. Effect of vaccination on the severity and dissemination of whooping cough. BMJ 1981; 282: 1925–8.
16. Swansea Research Unit of the Royal College of General Practitioners. Effect of a low pertussis vaccination uptake on a large community. BMJ 1981; 282: 2336.
17.Miller CL, Fletcher WB. Severity of notified whooping cough. BMJ 1976; i: 117–19.
18.Palmer SR. Vaccine efficacy and control measures in pertussis. Arch Dis Child 1991; 66: 854–7.
19.Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988; 10: 212–41.
20.Fine PEM, Clarkson JA. Reflections of the efficacy of pertussis vaccines. Rev Infect Dis 1987; 9: 866–83.
21.Farrington CP. The measurement and interpretation of age specific vaccine efficacy. Int J of Epidemiol 1992; 21: 1014–20.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 2 *
Loading metrics...

Abstract views

Total abstract views: 93 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th October 2017. This data will be updated every 24 hours.